Status:
COMPLETED
Prehospital Norepinephrine and Early Mortality in Traumatic Shock
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
Beaujon Hospital
University Grenoble Alps
Conditions:
Traumatic Shock
Hemorrhagic Shock
Eligibility:
All Genders
18-90 years
Brief Summary
The effect of early, prehospital norepinephrine use in patients with traumatic shock on mortality is unknown. Recent existing observational evidence from single system data (US, France, Japan) are con...
Detailed Description
Prehospital hypotension is associated with worse clinical outcomes in patients who sustain traumatic injuries. Administration of vasoactive medications, including norepinephrine, is not advocated in N...
Eligibility Criteria
Inclusion
- Age 18-90 years
- Blunt traumatic mechanism of injury
- Admitted to the trauma center from the scene of injury
- Systolic blood pressure during prehospital transport or at admission to the trauma center \<100 mmHg
Exclusion
- Penetrating mechanism of injury
- No vital signs at the scene of injury
- Prehospital cardiac arrest
- Transferred to the trauma center from another hospital
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
2164 Patients enrolled
Trial Details
Trial ID
NCT04497155
Start Date
January 1 2013
End Date
December 31 2021
Last Update
February 10 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.